CANNABIS ROUTES OF ADMINISTRATION
Nowadays registered cannabis patients, including wellness patients are more educated on cannabinoids and want greater control of their cannabis to treat their specific diagnosis. The growing popularity of certain routes of administration like oral, sublingual, and edible can be attributed to their standardized dosages. Inconspicuously absent from this list is dried flower inhalation aka smoking, where administration instructions are usually a 1-2 second draw, referring to pre-rolls, or whole flower/pre-ground for combustible consumption by smoking. It is difficult to achieve specific outcomes with dried flower without a standardized formulation and dosing, system, and method.
What is BRAZIER™?
BRAZIER MDI-P™ is a metered dose inhaler-pipette (MDI-P) a medical-grade device engineered for microdosing botanical cannabis in dried flower form. The BRAZIER MDI-P™ formulates a 1/8 teaspoon microdose of dried flower cannabis for inhalation. It delivers a thrice filtered microdose, void of harmful or potentially harmful constituents (HPHCs).
A 1/8 tsp microdose is equivalent to .625 mL by volume of cannabis flower. For example: If the cannabis flower strain contains 10% THC & 5% CBD, then the 1/8 tsp microdose is 6.25 mg THC & 3.125 mg CBD.
Who is BRAZIER™ for?
BRAZIER MDI-P™ is a medical grade device engineered for patients who consume dried flower cannabis via inhalation, which is the most used consumption method. It is also an ancillary conduit for clinical research on some of the listed diagnoses for which patients are prescribed dried flower cannabis.
BRAZIER MDI-P™ delivers a standardized microdose of cannabis flower ensuring patients receive the same exact formulation and dose each time, thus helping researchers better define strain and dosing efficacy. It gives patients and their physicians greater control to monitor use and effects of medical cannabis consumption, and regulate it in efficacy of prescribed treatment.